Literature DB >> 9209270

Experimental immune-mediated damage of septal cholinergic neurons.

J Kálmán1, J I Engelhardt, W D Le, W Xie, I Kovacs, P Kása, S H Appel.   

Abstract

Degeneration of cholinergic neurons in the medial septum and the diagonal band of Broca is a frequent neuropathological feature of Alzheimer's disease. To determine whether an immune process can injure these basal forebrain cholinergic neurons, we serially immunized guinea pigs with septal cholinergic hybrid cells (SN-56). Following immunization, a relatively selective damage of septal cholinergic neurons, reduction in septal choline acetyltransferase (ChAT) activity and decrease in acetylcholine release in hippocampus were detected. Serum IgG from guinea pigs immunized with SN-56 cells and stereotactically injected into the medial septal region of rats produced a loss of ChAT activity in the medial septum, frontal cortex and hippocampus, together with impairment of learning and long term spatial memory. These data suggest that relatively selective damage to septal cholinergic neurons can be caused by an immune-mediated process in experimental animals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209270     DOI: 10.1016/s0165-5728(97)00062-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6/STAT3 signaling pathway.

Authors:  Zhong-Ming Qian; Xuan He; Tuo Liang; Ka-Chun Wu; Yik-Chun Yan; Li-Na Lu; Guang Yang; Qian Qian Luo; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2014-12       Impact factor: 5.590

3.  Interleukin-2 deficiency-induced T cell autoimmunity in the mouse brain.

Authors:  Zhi Huang; Daniel J Dauer; Grace K Ha; Mark H Lewis; John M Petitto
Journal:  Neurosci Lett       Date:  2009-07-10       Impact factor: 3.046

4.  Current experimental therapy for Alzheimer's disease.

Authors:  Sheng Chen; Xiao-Jie Zhang; Liang Li; Wei-Dong Le
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.